CGS 30440

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2008
0119972008

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
BACKGROUND The association of an angiotensin-converting enzyme inhibitor (ACEI) with a neutral endopeptidase inhibitor (NEPI) has… (More)
Is this relevant?
1999
1999
For nearly two decades, angiotensin converting enzyme (ACE) inhibitors have been used in the management of hypertension and as… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
1998
1998
Dual angiotensin-converting enzyme (ACE)/neutral endopeptidase (NEP) inhibitors, by decreasing angiotensin-II production and by… (More)
  • figure 2
  • figure 1
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
1998
1998
The purpose of these studies was to compare the effects of CGS 30440 (CGS), a dual angiotensin-converting enzyme inhibitor (ACEI… (More)
Is this relevant?
1998
1998
Dual angiotensin-converting enzyme (ACE)/neutral endopeptidase (NEP) inhibitors, by decreasing angiotensin-II production and by… (More)
  • figure 2
  • figure 1
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
1997
1997
This study examined the long-term effects of CGS 30440 on blood pressure, heart rate, cardiac hypertrophy, and urinary parameters… (More)
Is this relevant?